JPS59501949A - 避妊用膣錠およびその製造法 - Google Patents
避妊用膣錠およびその製造法Info
- Publication number
- JPS59501949A JPS59501949A JP83503243A JP50324383A JPS59501949A JP S59501949 A JPS59501949 A JP S59501949A JP 83503243 A JP83503243 A JP 83503243A JP 50324383 A JP50324383 A JP 50324383A JP S59501949 A JPS59501949 A JP S59501949A
- Authority
- JP
- Japan
- Prior art keywords
- parts
- weight
- tablets
- sodium bisulfite
- vaginal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002254 contraceptive effect Effects 0.000 title claims description 10
- 239000003433 contraceptive agent Substances 0.000 title claims description 9
- 239000000003 vaginal tablet Substances 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 20
- 239000003826 tablet Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 13
- 239000011782 vitamin Substances 0.000 claims description 13
- 229940088594 vitamin Drugs 0.000 claims description 13
- 229930003231 vitamin Natural products 0.000 claims description 13
- 235000013343 vitamin Nutrition 0.000 claims description 13
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 11
- 235000002906 tartaric acid Nutrition 0.000 claims description 11
- 239000011975 tartaric acid Substances 0.000 claims description 11
- 235000019359 magnesium stearate Nutrition 0.000 claims description 10
- QJQRNDGUWQVAEV-AAFSJPGBSA-M sodium bisulfite adduct Chemical compound [Na+].[O-]S(=O)(=O)C([C@H]1N(C(C2=C3)=O)C=C(C1)/C=C/C(=O)N(C)C)NC2=CC1=C3OCO1 QJQRNDGUWQVAEV-AAFSJPGBSA-M 0.000 claims description 10
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 9
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 9
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 9
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 9
- 229940044977 vaginal tablet Drugs 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 2
- 239000000203 mixture Substances 0.000 description 10
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 9
- 239000008101 lactose Substances 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 150000003722 vitamin derivatives Chemical class 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 235000010980 cellulose Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 5
- 230000035935 pregnancy Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 230000003054 hormonal effect Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 229940125697 hormonal agent Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 241000276457 Gadidae Species 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023129 Jaundice cholestatic Diseases 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- 201000005267 Obstructive Jaundice Diseases 0.000 description 1
- 241000036848 Porzana carolina Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000031271 Unwanted pregnancy Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU823211A HU186134B (en) | 1982-10-07 | 1982-10-07 | Process for the production of contraceptive suppository tablets |
| HU3211/82 | 1982-10-07 | ||
| PCT/HU1983/000052 WO1984001502A1 (en) | 1982-10-07 | 1983-10-07 | Contraceptive vaginal tablets and manufacturing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS59501949A true JPS59501949A (ja) | 1984-11-22 |
Family
ID=10963124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP83503243A Pending JPS59501949A (ja) | 1982-10-07 | 1983-10-07 | 避妊用膣錠およびその製造法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4565694A (OSRAM) |
| EP (1) | EP0121543B1 (OSRAM) |
| JP (1) | JPS59501949A (OSRAM) |
| AT (1) | ATE19947T1 (OSRAM) |
| AU (1) | AU558286B2 (OSRAM) |
| DE (1) | DE3363794D1 (OSRAM) |
| DK (1) | DK156619C (OSRAM) |
| FI (1) | FI77781C (OSRAM) |
| HU (1) | HU186134B (OSRAM) |
| IL (1) | IL70051A (OSRAM) |
| IN (1) | IN162846B (OSRAM) |
| WO (1) | WO1984001502A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU199615B (en) * | 1986-06-23 | 1990-02-28 | Agardi Mezoegazdasagi Kom | Method and apparatus for pulsation drying granular capillary-porous matters particularly cereals by predried medium |
| IT1213323B (it) * | 1986-08-07 | 1989-12-20 | Crinos Industria Farmaco | Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida |
| US5116619A (en) * | 1988-08-30 | 1992-05-26 | Lee Roy Morgan | Vaginal progesterone tablet |
| WO2006087733A1 (en) * | 2005-01-19 | 2006-08-24 | Kamalinder Kaur Singh | Herbal contraceptive formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3062715A (en) * | 1953-11-18 | 1962-11-06 | George S Pfaus | Vaginal tablet |
| NL272519A (OSRAM) * | 1961-12-14 | 1964-08-17 | ||
| US4031202A (en) * | 1975-12-08 | 1977-06-21 | The Procter & Gamble Company | Controlled release contraceptive article |
| DE2602297B1 (de) * | 1976-01-22 | 1977-01-13 | Merz & Co | Vaginalzaepfchen zur empfaengnisverhuetung mit einem gehalt an milchalbumin |
| JPS5845403B2 (ja) * | 1976-02-14 | 1983-10-08 | エーザイ株式会社 | 補酵素ｑを主成分とする膵機能亢進剤 |
| US4242359A (en) * | 1977-04-01 | 1980-12-30 | Cornell Research Foundation, Inc. | Spermicidal agents |
| US4439441A (en) * | 1979-01-11 | 1984-03-27 | Syntex (U.S.A.) Inc. | Contraceptive compositions and methods employing 1-substituted imidazole derivatives |
| US4432967A (en) * | 1982-06-25 | 1984-02-21 | National Starch And Chemical Corp. | Contraceptive composition |
-
1982
- 1982-10-07 HU HU823211A patent/HU186134B/hu not_active IP Right Cessation
-
1983
- 1983-10-07 DE DE8383903196T patent/DE3363794D1/de not_active Expired
- 1983-10-07 US US06/621,905 patent/US4565694A/en not_active Expired - Fee Related
- 1983-10-07 EP EP83903196A patent/EP0121543B1/de not_active Expired
- 1983-10-07 WO PCT/HU1983/000052 patent/WO1984001502A1/en not_active Ceased
- 1983-10-07 AT AT83903196T patent/ATE19947T1/de not_active IP Right Cessation
- 1983-10-07 JP JP83503243A patent/JPS59501949A/ja active Pending
- 1983-10-07 AU AU20759/83A patent/AU558286B2/en not_active Ceased
- 1983-10-26 IL IL70051A patent/IL70051A/xx unknown
- 1983-11-29 IN IN1462/CAL/83A patent/IN162846B/en unknown
-
1984
- 1984-06-06 FI FI842284A patent/FI77781C/fi not_active IP Right Cessation
- 1984-06-06 DK DK279184A patent/DK156619C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI77781C (fi) | 1989-05-10 |
| FI842284A7 (fi) | 1984-06-06 |
| EP0121543B1 (de) | 1986-05-28 |
| DK156619C (da) | 1990-02-12 |
| DK279184D0 (da) | 1984-06-06 |
| ATE19947T1 (de) | 1986-06-15 |
| FI77781B (fi) | 1989-01-31 |
| AU558286B2 (en) | 1987-01-22 |
| DK156619B (da) | 1989-09-18 |
| WO1984001502A1 (en) | 1984-04-26 |
| IL70051A (en) | 1986-12-31 |
| US4565694A (en) | 1986-01-21 |
| FI842284A0 (fi) | 1984-06-06 |
| IN162846B (OSRAM) | 1988-07-16 |
| AU2075983A (en) | 1984-05-04 |
| EP0121543A1 (en) | 1984-10-17 |
| DE3363794D1 (en) | 1986-07-03 |
| HU186134B (en) | 1985-06-28 |
| DK279184A (da) | 1984-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2542779C2 (ru) | Способ контрацепции, используемый по мере необходимости | |
| Xu et al. | A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China | |
| Herd, Neil & Jordan | An investigation of malaria during pregnancy in Zimbabwe | |
| TW491704B (en) | New hormonal composition and its use | |
| Endrikat et al. | A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel, with respect to efficacy, cycle control and tolerance | |
| JP5036943B2 (ja) | 新規なホルモン組成物とその利用 | |
| TWI280877B (en) | Beta-agonists for treating endometriosis or infertility, or improving fertility | |
| JPS59501949A (ja) | 避妊用膣錠およびその製造法 | |
| Schwallie | The effect of depot-medroxyprogesterone acetate on the fetus and nursing infant: a review | |
| WO2006082596A2 (en) | Neem oil contraceptive formulations | |
| Apelo et al. | Postpartum IUD insertions in Manila, Philippines | |
| Hollingsworth | Drugs and pregnancy | |
| Coutinho | Conservative treatment of uterine leiomyoma with the antiestrogen antiprogesterone R‐2323 | |
| CA1214725A (en) | Contraceptive vaginal tablets and process for preparing them | |
| Fisher | Missed Abortion: Analysis of 30 cases and discussion of etiology | |
| Singh et al. | Norplant®-2 rods: One year experience in Singapore | |
| Jaiswal et al. | Effectiveness and Safety of Levonorgestrel Intrauterine Device in Abnormal Uterine Bleeding, Adenomyosis and Perimenopausal Bleeding Patients. | |
| Haynes et al. | In postpartum patients, does immediate postplacenta IUD placement compared with IUD placement at 6 weeks postpartum decrease short-interval pregnancies? | |
| NZ206039A (en) | Contraceptive vaginal tablets containing boric acid and vitamin k3 | |
| Khanum et al. | Efficacy of Unani formulation in unexplained primary infertility–A | |
| Bhavani | Chapter-11 Family Planning | |
| Lavin et al. | Preliminary report on a postpartum CuT 200 study, Santiago, Chile | |
| Rabe | Contraception-Update and trends | |
| CN114129530A (zh) | 一种黄体酮缓释组合物及其制备方法 | |
| Puri et al. | A review of best birth control options for adolescents |